N-[3-[(3R)-3-tert-butylpiperidin-1-yl]-5-(trifluoromethyl)phenyl]-1-(3,5-difluorophenyl)-1,2,4-triazol-3-amine
C24H26F5N5 — CID 159838506
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[(3R)-3-tert-butylpiperidin-1-yl]-5-(trifluoromethyl)phenyl]-1-(3,5-difluorophenyl)-1,2,4-triazol-3-amine
N-[3-[(3R)-3-tert-butylpiperidin-1-yl]-5-(trifluoromethyl)phenyl]-1-(3,5-difluorophenyl)-1,2,4-triazol-3-amine (PubChem CID 159838506) has the molecular formula C24H26F5N5 and a molecular weight of 479.50 g/mol. Its IUPAC name is N-[3-[(3R)-3-tert-butylpiperidin-1-yl]-5-(trifluoromethyl)phenyl]-1-(3,5-difluorophenyl)-1,2,4-triazol-3-amine.
Molecular Properties
| Compound Name | N-[3-[(3R)-3-tert-butylpiperidin-1-yl]-5-(trifluoromethyl)phenyl]-1-(3,5-difluorophenyl)-1,2,4-triazol-3-amine |
|---|---|
| PubChem CID | 159838506 |
| Molecular Formula | C24H26F5N5 |
| Molecular Weight | 479.50 g/mol |
| Exact Mass | 479.21 |
| IUPAC Name | N-[3-[(3R)-3-tert-butylpiperidin-1-yl]-5-(trifluoromethyl)phenyl]-1-(3,5-difluorophenyl)-1,2,4-triazol-3-amine |
| SMILES | CC(C)(C)[C@H]1CCCN(c2cc(Nc3ncn(-c4cc(F)cc(F)c4)n3)cc(C(F)(F)F)c2)C1 |
| InChI | InChI=1S/C24H26F5N5/c1-23(2,3)15-5-4-6-33(13-15)20-8-16(24(27,28)29)7-19(12-20)31-22-30-14-34(32-22)21-10-17(25)9-18(26)11-21/h7-12,14-15H,4-6,13H2,1-3H3,(H,31,32)/t15-/m0/s1 |
| InChIKey | RYXJYPQNHXBKAZ-HNNXBMFYSA-N |
| XLogP | 6.57 |
| TPSA | 45.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 479.50 |
| LogP ≤ 5 | 6.57 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159838506 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.